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Abstract
Background:  Since 9% to 20% of all cases of acute psychosis presenting to an Emergency
Department (ED) are due to a general medical condition, cautious medical workup should be
mandatory in such patients. Differential diagnosis must consider conditions as diverse as renal
failure or CNS infection.
Acute Chlamydia pneumoniae infection usually causes a self-limited respiratory syndrome. Rarely,
acute neurological complications occur, with acute meningoencephalitis most frequently reported.
Diagnosis requires a high level of suspicion and is difficult to confirm.
Case report: We describe a 22 year-old female Caucasian who, three days after a mild pharingitis,
developed an acute psychosis with exuberant symptoms interspersed with periods of lucidity, in a
background of normal consciousness and orientation.
Initial medical and imagiological workup were inconclusive. After 20 days of unsuccessful treatment
with antipsychotics she developed a high fever and was re-evaluated medically. Lumbar puncture
revealed an inflammatory cerebrospinal fluid. MRI showed irregular thickening and nodularity of the
lateral ventricles' lining. An anti-Chlamydia pneumoniae IgM antibody titter of 85 IU/ml was
detected. All symptoms cleared after treatment with antibiotics and corticosteroids.
Conclusion:  This is, to our knowledge, the first reported case of acute CP-associated
meningoencephalitis manifesting as an acute psychotic episode. It illustrates the principle that non-
organic psychiatric syndromes must remain a diagnosis of exclusion in first-time acute psychosis.
Background
It is estimated that between 9% and 20% of all cases of
acute psychosis presenting to an Emergency Department
(ED) are due to a general medical condition [1-3]. This
means that all patients coming to the ED with signs and
symptoms of acute psychosis must undergo a careful diag-
nostic workup. Apart from non-organic psychiatric syn-
dromes themselves, the differential diagnosis must
include physical trauma, drugs and toxins, organ failure
(e.g., renal failure), structural lesions like intracranial
hematomas or neoplasms, infections and nutritional defi-
ciencies like vitamin B12 deficiency or pellagra [1-4]. The
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psychiatrist plays a fundamental role in this process and is
often the last resort that keeps the patient from sliding
down the almost no-return path of an erroneous non-
organic psychiatric diagnosis [2,4,5]. The sudden onset of
psychosis in a 40 year-old patient with no personal or
family history of psychiatric disease who shows recent
memory loss, altered vital signs and a clouded conscious-
ness with disorientation and visual hallucinations will
probably be easily identified as a possible medical condi-
tion manifesting through behavioural changes [5]. Many
cases, however, do not present such clear-cut features and
false beliefs (i.e. delusions) may actually constitute the
sole manifestation of central nervous system disfunction
(CNS) [6]. Such patients often come to constitute a true
challenge to the attending psychiatrist.
Chlamydia pneumoniae (CP) is an intracellular organism
with worldwide distribution and is pathogenic both to
humans and other vertebrates. The metabolically inactive
but infectious extracellular form (elementary body) differ-
entiates into reticulate body after endocytosis by macro-
phages/monocytes, endothelial cells or vascular smooth
muscle cells. Within these cells it then replicates by binary
fission [7]. It is currently speculated that the respiratory
tract be the site of entry for CP, from whence it is then
transported by monocytes or macrophages to other sites
in the organism. It remains unclear how CP infection
leads to disease, as it does not produce toxins and has only
weak lipopolysaccharide activity [8]. In humans CP most
frequently causes a self-limited and uneventful acute res-
piratory tract syndrome. More rarely it can cause multior-
ganic disease with an occasionally fatal outcome [8,7,9].
Over the last few years CP has become the object of
intense debate among neurologists as being possibly
involved in the aetiology of such diverse conditions as
Alzheimer's disease, multiple sclerosis or atherosclerosis
(this last possibility earning it the ironical nickname "car-
diology's Helicobacter") [10-18]. Acute neurological com-
plications of CP infection seem to be rare [10]; as to our
knowledge no more than twenty putative cases with vari-
able manifestations have been published so far [19-25].
Meningoencephalitis has been by far the most frequently
reported situation, with isolated reports of meningo-
radiculitis, polyradiculoencephalitis, cerebelar disfunc-
tion, Guillain-Barré syndrome and acute disseminated
encephalomyelitis. In most such cases direct evidence of
central nervous system (CNS) involvement by CP in has
been difficult to obtain; to our knowledge only three cases
have been reported where intrathecal production of spe-
cific anti-CP antibodies was demonstrated [19-21]. In a
further case the authors claim to have detected CP anti-
gens in their patient's CSF and more recently a case was
reported where intrathecal presence of CP DNA was
detected by PCR [23,25].
Case report
A 22 year-old single, Caucasian female Business-school
student developed a low fever, headache and sore throat,
which remitted spontaneously after three days. Seven days
after the start of these symptoms she suddenly became
agitated, physically and verbally aggressive, with total
insomnia and disrupted behaviour. She was taken by her
parents to the Emergency Department of S. Francisco
Xavier Hospital, Lisbon, and was compulsorily hospital-
ised in the acute psychiatric ward under the Portuguese
Mental Health Law. The mental state examination
revealed a vigil and fully oriented patient. She appeared
distrustful, collaborated poorly and was easily distracted.
She had false delusional memories and paranoid delu-
sional, poorly structured ideas of persecutory, magical and
grandiose content, as well as a disrupted awareness of the
boundaries and vitality of the Self. She also claimed, in
what appeared to be a delusional misidentification of the
Capgras syndrome type, that robots had replaced her par-
ents. She appeared to be suffering complex auditive hallu-
cinations in the 2nd and 3rd person, with a menacing
content. Her mood was dysphoric, with poorly contained,
labile affects. Her past medical record and family history
were irrelevant. Neurological and general physical exami-
nations were normal. She was started on haloperidol 10
mg tid ev (she refused oral medication), with no improve-
ment of her mental state, although she did have unpre-
dictable, short-lived intervals of remarkable lucidity with
almost total absence of psychiatric symptoms apart from
a depressed mood. 20 days after admission she developed
a high fever with a white-cell count of 27 × 109/L, an
erythrocyte sedimentation rate (ESR) of 100 mm/h and a
C-reactive protein (CRP) of 15.3 mg/L. Routine biochem-
istry studies were normal. The cerebrospinal fluid (CSF)
was clear, with normal protein and glucose concentra-
tions and 20 × 106 lymphocytes per litre. Microbiological
investigation of CSF was negative. Her chest film and
brain CT-scan showed no changes. Brain MRI showed
irregular thickening and nodularity of the lateral ventri-
cles' lining. A complete neuropsychological evaluation
was performed revealing a mild impairment of her exter-
nal visual attention and visuo-constructive reproduction
capacity. The EEG displayed symmetrical, irregular, high
amplitude, slow wave activity with frontotemporal pre-
dominance. An ophthalmologic examination revealed
lymphocytes in her vitreum. A skin biopsy was taken for
Lupus Band Test, which was negative. Serologic testing of
serum and CSF was performed for systemic lupus ery-
thematosus (including anti-ribosomal P antibodies) and
other connectivites as well as for most known neurotropic
viruses and bacteria. An IgG antibody titer to CP of 22 IU/
ml was detected in the serum, with an IgM antibody titer
of 85 IU/ml. No anti-CP antibodies were detected in the
CSF. All her psychotropic medication was stopped and
she was started on levofloxacin (due to dysuria and leuko-Clinical Practice and Epidemiology in Mental Health 2005, 1:15 http://www.cpementalhealth.com/content/1/1/15
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cyturia) and acyclovir. Five days levofloxacin was changed
to gentamicin plus piperacillin/tazobactam for due to
Escherichia coli-positive blood-cultures (serological
results were not yet available at that time). She finally
received three consecutive ev pulses of methylpred-
nisolone (1 g each), before being transferred to a Neurol-
ogy unit. During the following week she progressively
became apyretic and her psychotic symptoms gradually
remitted. At the time of discharge, eight weeks after admis-
sion, she still had an ESR of 55 mm/h and a CRP of 9.03
mg/L, with normal blood count and biochemical param-
eters as well as a normal CSF. Brain MRI nine weeks after
admission showed complete remission of the initial
changes. At the time of discharge, the EEG still displayed
symmetrical, irregular, high amplitude, slow wave activity
with frontotemporal predominance, although much less
severe than in the first EEG record.
Psychiatrically she remained slightly disinhibited, both
verbally and affectively, with pedolalia and mildly child-
ish behaviour. There were no signs of delusional ideas or
hallucinations and she could only vaguely remember the
period when she had been psychotic. Two months after
discharge she had resumed her studies and concluded her
Business School degree.
Discussion
This is, to our knowledge, the first reported case of an
acute CP-associated meningoencephalitis manifesting as a
first-episode acute psychosis.
In our patient the initial manifestations were interpreted
as a purely non-organic psychiatric syndrome, which led
to a delay of several weeks not only in the definitive diag-
nosis but also in the appropriate treatment. The patient's
young age, her clear consciousness and normal orienta-
tion, the presence of archetypical first-rank symptoms of
schizophrenia and specially her normal physical and neu-
rological examinations were all factors contributing to the
premature exclusion of a medical condition as an explana-
tion for the patient's behavioural changes. This illustrates
how easy it can be to miss an organic brain syndrome at
an early stage once a psychiatric diagnosis is taken into
consideration and in the absence of such gross indicators
as age greater than 40 years, disorientation with clouded
consciousness or abnormal vital signs. Retrospectively we
can identify several subtle cues in our patient pointing to
a medical aetiology, namely the sudden onset of severe
and exuberant psychiatric changes, the patient's high level
of functioning prior to the episode and negative family
history for psychiatric disorders, her intense emotional
unsteadiness, the temporal relationship to a minor infec-
tious episode, the existence of occasional "islands" of
lucidity and the symptoms' minimal response to antipsy-
chotic agents. All of these have been consistently reported
in the literature as discrete but highly significant indica-
tors of acute organic brain disorder [1,2,4,5,26,27].
A pertinent question in this context is which diagnostic
methods should be included in the initial workup of first-
episode acute psychosis. Although most would probably
include a no-contrast brain CT scan in their initial evalua-
tion, this is actually a method lacking in sensitivity [1-
3,27]. On the other hand, MRI scanning is probably una-
vailable in most EDs. Also, the decision threshold for per-
forming a lumbar puncture should be much lower, since
it remains the most reliable method of detecting inflam-
matory changes of the CNS [1,3].
Our case is also worthy of discussion from the perspective
of infectiology, especially insofar as the final bacteriolog-
ical diagnosis is concerned. CP infection of the CNS is dif-
ficult to diagnose and requires a high level of suspicion.
Detection of the organism's DNA in the CSF using
polymerase chain reaction (PCR) probably constitutes the
most reliable method of confirming the diagnosis
[25,28,29]. Unfortunately, this is a method that is not
always available, as it is the case in our hospital. However,
the elevated titer of CP IgM antibodies in the serum and
the absence of any other possible aetiology after exhaus-
tive investigation make CP the almost certain cause of
meningoencephalitis in our patient. To our knowledge
only three cases where intrathecal synthesis of CP anti-
bodies was demonstrated have been published so far and
most reports of the rare acute neurological complications
of CP infection have been based on serum antibody titers
only [19-21]. Moreover, Sočan et al, using a direct-
immunfluorescence test with CP-specific monoclonal
antibodies, reported a case where they detected CP anti-
gens in their patient's CSF, which showed negative anti-
body titers by microimmunofluorescence assay [23].
Doubt has been cast by several authors on the reliability
of single antibody titer measurements in the serum for the
diagnosis of acute CP infection and it now seems unani-
mous that this method's sensitivity is unsatisfactory
[28,29]. The case for specificity, however, remains open to
controversy. Although Gaydos et al detected antibody
titles considered to be diagnostic of acute infection with
CP in 18,8% of 80 PCR and culture negative individuals,
it must be stressed that this was a sample of asymptomatic
persons and so their results can in no way be extrapolated
to severely ill patients presenting with clinical manifesta-
tions compatible with CP infection and in whom most
alternative infectious agents have been exhaustively
excluded. On the other hand, Sočan et al, in their reply to
the letter to their editor by Weiss et al, claim to have found
no single positive anti-CP IgM titer in samples from 100
blood donors [28]. Finally, it is probably also relevant
that the abovementioned works have used microimmun-Clinical Practice and Epidemiology in Mental Health 2005, 1:15 http://www.cpementalhealth.com/content/1/1/15
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ofluorescence assays for measuring antibody titers in the
serum, while our patient was studied using an enzyme-
linked imunosorbent assay. The whole controversy
around which is the most reliable method for detecting
CP infection of the CNS actually developed in connection
with attempts to link the organism to the aetiology of
Multiple sclerosis, Alzheimer's disease or atherosclerosis,
leading to the active search for CP in patients with no
other evidence of infection by CP than the above-men-
tioned conditions themselves [11-13,15-17,30]. To be
conclusive, this kind of investigation must strive for a
degree of certainty and unambiguity in their methods
whose sophistication and complexity are probably inade-
quate for everyday use in a clinical context.
Another important question in our case is what caused the
patient to improve. The fact that she only received levo-
floxacin for five days (serological results were only availa-
ble after the patient had started to improve) and her rapid
recovery after corticosteroid therapy suggests that the
acute neurological complications of CP infection might
be attributed to an autoimmune mechanism, rather than
to the organism's direct action. Frydén et al have previ-
ously reported improvement after corticosteroid therapy
in CP-associated meningoencephalitis (although their
patient also received cloramphenicol) [31]. The CP-asso-
ciated Guillain-Barré syndrome reported by Haidl also
recovered only after treatment with methylprednisolone
[24]. The encephalitis case reported by Airas et al suffered
further clinical and imagiological progression in spite of
CP-active antibiotic treatment (levofloxacin) [19]. The
case reported by Michel et al eventually recovered from
lumbosacral meningoradiculitis without antibiotic treat-
ment [21]. Finally, Grayston et al described a case where
acute CP reinfection led to a sarcoidosis-like clinical pic-
ture and raise the possibility of an immunopathologic
reaction in their patient [9].
In spite of our current ability to detect structural and func-
tional changes of the CNS in organic brain syndromes, it
remains unclear how these changes relate to the behav-
ioural changes and in what way such observations might
be extrapolated to our understanding of the pathophysiol-
ogy of non-organic psychosis. In the present case the only
observable changes seemed to concentrate around the
ependymal axis. Peri-aqueductal structures have recently
been considered by a few authors to be the neurostruc-
tural backbone of consciousness and especially of the con-
sciousness of the self, whose disturbance constitutes one
of essential features of schizophrenic psychosis [32,33].
This concept is in full accordance to the observations by
Cummings et al, who found that in organic psychosis
complex symptomatology such as Schneiderian first-rank
symptoms is more frequently associated with subcortical
lesions. This probably means that complex psychotic syn-
dromes require that higher CNS functions like linguistic
and verbally-mediated conceptual abilities and the corre-
sponding cortical structures be intact. Subcortically gener-
ated abnormal emotional experiences can thus be fully
elaborated at higher levels into complex delusional and
hallucinatory syndromes [6]. Interestingly, organic psy-
chosis due to subcortical brain lesions also seem to be par-
ticularly resistant to antipsychotic treatment, which was
one of the striking features of our patient [6].
Conclusion
As we stressed before, this is to our best knowledge the
first reported case of an acute CP-associated meningoen-
cephalitis manifesting as a first-episode acute psychosis
and illustrates the overwhelming importance of a careful
medical and neurological diagnostic workup before a sud-
den first-time psychotic episode receives a "non-organic"
psychiatric diagnosis. In such cases non-organic psychiat-
ric diagnosis should remain a diagnosis of exclusion [1,4],
and thus approached with the assumption that the cause
of psychosis is an organic one [4]. As diagnostic methods
grow more complex and as we become more able to diag-
nose unusual medical aetiologies for common psychiatric
syndromes, more and more will be demanded from clini-
cal psychiatrists in terms of general medical knowledge
and ability to work fully integrated with other specialities.
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